Aditya Palepu, the big boss at DEX Labs (he’s basically the superhero of crypto derivatives), says this MEV nonsense keeps the serious financial folks from jumping into DeFi-probably because they don’t fancy getting sandwiched or front-run before they even place their order. Imagine trying to buy a burger, only to find someone else ordered it first and then jacked up the price! 😂
in a world where the line between hero and profiteer blurs, who watches the watchers? 🕵️♂️
According to Jurgilas, the future of finance isn’t about speculative hype (though we all love a good bubble, don’t we? 🧼💸). No, it’s about regulated scale, compliance, and trust-the holy trinity of institutional opportunity, worth trillions of space credits. 🏦💰
Trade direction: buy; position now represents 3.48% of the reported 13F assets under management. The long-term gambler watches, as the markets unfold like the slow march of time itself, witnessing new twists as old stakes are gradually raised.
Dogecoin (DOGE), the once-mighty doge of the crypto realm, now limps along with a mere 0.6% gain, as if it’s been chased by a very grumpy squirrel. Stagnating at $0.1871, it’s like a teacup that forgot how to sip. Dogecoin’s market cap, $27.4 billion, is a number so large it could buy a small island… if the island was made of paper. 🐕💸
According to a document filed with the Securities and Exchange Commission (a body whose primary purpose seems to be ensuring that paperwork remains the universe’s most enduring constant), Palisades had, during the third quarter, divested itself entirely of ADMA Biologics. This involved the sale of 398,647 shares, a number that sounds precise until you realize it’s roughly the population of a small island nation. The fund now holds precisely zero ADMA shares, a state of affairs as absolute as the heat death of the universe.
Weighted average price? A nice round $169.56 per share-now that’s a good day at the office.
Yet, let us not mistake ambition for substance. Upstart, though bold, remains a modest creature, its market cap a mere $4.5 billion-a pittance compared to the leviathan of Affirm. The stock, a ghost of its former self, lingers 88% below its peak, as if haunted by the specter of past misfortunes.
Upon delving into Master Martinez’s recent offering upon the ‘X’ platform, it is revealed that Solana’s trajectory has, since May of the not-so-far-off year 2025, been ensnared within an ascending channel as unwavering as Darcy’s resolve. Yet, such discipline has scarcely averted a flirtation with the channel’s lower threshold at about $180-yet another lighthouse in the mist for the discerning investor. Moreover, this pivotal support coalesces, by some stroke of fate, with the 200-day simple moving average, lending significant credence to its relevance. Bravo, Mr. Byronic!
Brace yourselves for the grand debut of Canary Capital’s XRP ETF, set to grace the stage on November 13, 2025, like a debutante at a masquerade ball. After filing faster than a Parisian waiter dodging a bad tip, this ETF could auto-debut 20 days post-submission. If approved, it’ll join the crypto-elite club, where Bitcoin and Ethereum already sip champagne on yachts. 🥂
